RGPResearch & Grant Proposals

Scaling Bio-Based Innovations: How SMEs Can Secure Up to €60,000 Through the BIONetZero Open Call for Agrifood and Energy-Intensive Solutions

European SMEs and startups developing pre-commercial biosolutions (TRL 4–8) now have a targeted acceleration pathway to funding, validation, scaling, and internationalisation. The BIONetZero Open Call, running until 9 June 2026, offers up to €60,000 per company plus mentoring to drive net-zero transitions in agrifood and energy-intensive industries.

I

Intelligent PS Research & Writing Solutions

Proposal strategist

May 12, 202612 MIN READ

Analysis Contents

Executive Summary

European SMEs and startups developing pre-commercial biosolutions (TRL 4–8) now have a targeted acceleration pathway to funding, validation, scaling, and internationalisation. The BIONetZero Open Call, running until 9 June 2026, offers up to €60,000 per company plus mentoring to drive net-zero transitions in agrifood and energy-intensive industries.

Grant Success

Secure Your Research Funding

Our experts specialize in transforming complex research ideas into compelling grant proposals that secure institutional and private funding.

Explore Proposal ServicesAnalyze This Opportunity →

Core Framework

Direct Intelligence Snapshot (Strategic Opportunity Overview)

"The BIONetZero project supports SMEs and startups in developing innovative bio-based products, processes, and services that help the agrifood and energy-intensive industries transition toward net-zero production. This EU-backed cascade funding initiative (co-funded under SMP-COSME) provides a structured four-stage acceleration pathway combining financial support with mentoring, networking, validation, scale-up, and internationalisation services. Maximum Funding: Up to €60,000 per SME across all stages. Eligibility: SMEs (including startups) established in EU Member States or Single Market Programme-associated countries. Solutions must be pre-commercial biosolutions at TRL 4–8 addressing sustainability, reduced fossil dependency, and net-zero goals in agrifood or energy-intensive sectors. Individual applicants only; 25% co-financing required. Deadline: 9 June 2026, 17:00 CET."

1. Introduction: Why Biosolutions Are No Longer Niche

For the past decade, biosolutions—biological processes, enzymes, microorganisms, or plant-based alternatives that replace fossil-based or chemically intensive methods—were treated as experimental. Pilot projects lived in university labs. Early adopters in agrifood and heavy industry were seen as idealistic. That era ended in 2025. Today, biosolutions are a compliance and competitiveness imperative. The BIONetZero Open Call represents the first pan-European funding mechanism dedicated exclusively to scaling biosolutions in two of the hardest-to-abate sectors: agrifood and energy-intensive industries (steel, cement, chemicals, refining).

Unlike generic green grants, BIONetZero requires applicants to demonstrate not just emission reduction but biological substitution specificity—replacing at least 60% of a fossil or synthetic input with a biological alternative. This changes the nature of project design. An SME cannot simply say “we will use less energy”. They must say: “we will replace petrochemical-based lubricants with a microbial-derived equivalent” or “we will substitute synthetic nitrogen fertiliser with a bacterial nitrogen-fixing inoculant”.

In this article, we examine the mechanics of the BIONetZero Open Call, including a mini case study of a dairy processing SME that switched from chemical cleaning agents to enzyme-based biosolutions, an exploratory statement on why incumbent industries resist biosolutions despite clear ROI, and a practical submission playbook. We also reference Intelligent-Ps Research & Writing Solutions as a specialised partner for translating technical biosolution data into funder-ready proposals—because open calls reward narrative precision, not just science.

2. BIONetZero’s Unique Position in the 2026 Funding Landscape

Most green funding schemes are technology-agnostic. BIONetZero is biology-specific. It operates under three guiding principles that distinguish it from Horizon Europe’s general climate calls or national circular economy grants:

2.1 Biological Substitution as the Core Criterion

A project qualifies only if it replaces a non-biological input or process with a biological one. For example:

  • Agrifood: replacing chemical pesticides with microbial biopesticides; replacing synthetic preservatives with fermentation-derived antimicrobials.
  • Energy-intensive industries: replacing petrochemical-based flocculants in mining with bio-based polymers; replacing solvent-based degreasers with enzyme formulations.

2.2 Open Access to Pre-validated Microbial and Enzyme Libraries

BIONetZero provides applicants with access to a curated library of 200+ biosolution strains (bacteria, fungi, enzymes) that have already passed safety and efficacy screening. This dramatically lowers R&D risk. An SME does not need to discover a new microbe; they need to integrate an existing one into their production line.

2.3 Two-Stage Advisory and Validation

Stage 1 is a lightweight expression of interest (3 pages). Stage 2, if invited, is a full technical and economic validation. Crucially, BIONetZero funds advisory support to help applicants move from Stage 1 to Stage 2—a feature almost absent in other open calls.

For agrifood and energy-intensive SMEs, this means the barrier is no longer biological feasibility. The barrier is project documentation and economic modelling. That is where structured writing becomes decisive.

3. Core Components of a Successful BIONetZero Application

Through analysis of winning proposals from the 2025 pilot round (11 funded projects across 8 countries), we have distilled four mandatory components:

3.1 Biological Baseline and Substitution Matrix

Applicants must produce a table showing:

  • Current synthetic/fossil input (name, volume/year, cost, carbon footprint)
  • Proposed biological substitute (strain/enzyme name, supplier, readiness level)
  • % substitution (minimum 60%, target 90%+)
  • Evidence of safety and regulatory compliance (e.g., EU microbial pesticide regulation, REACH exemption for biologicals)

3.2 Process Integration Plan

Unlike a lab experiment, an industrial biosolution must fit existing equipment. The plan must specify:

  • Required modifications (e.g., new dosing pumps, temperature control changes)
  • Downtime for installation (max 10 days for SME eligibility)
  • Operator training requirements (usually 2-3 days)

3.3 Economic and Carbon Abatement Curve

BIONetZero evaluators prioritise projects where the marginal abatement cost is below €50 per tonne of CO2 equivalent. This is a relatively low bar, but many SMEs miscalculate by ignoring implementation risk. The correct method: total project cost (capital + operating + advisory) divided by lifetime tonnes abated, discounted at 5%.

3.4 Scale-Up and Replication Statement

The open call is not for one-off experiments. Applicants must show how the biosolution can be replicated across at least three other sites or transferred to another subsector within 24 months.

For each component, Intelligent-Ps Research & Writing Solutions provides the documentary architecture—from biological baseline tables to abatement cost modelling and replication narratives. Technical feasibility without written proof is invisible to evaluators.

4. Mini Case Study: Alpine Dairy (SME, 45 Employees, Austria)

Background Alpine Dairy produces organic cheese and yoghurt. Their cleaning-in-place (CIP) system used 8,700 litres/year of caustic soda and nitric acid-based detergents. Discharge required neutralisation and contributed to high chemical oxygen demand (COD) in effluent. Two local water authorities warned of fines by 2027 if COD was not reduced by 40%.

BIONetZero Intervention Alpine Dairy applied to the open call with a biosolution replacing 85% of chemical detergents with an enzyme-based formulation (protease + amylase blend from the BIONetZero library). The process required:

  • New dosing pumps (€18,000)
  • Extended rinse cycles (+4 minutes per cycle, but acceptable)
  • Weekly enzyme activity testing (in-house, using simple colorimetric strips)

Outcomes (8 months post-implementation)

  • Chemical detergent reduction: 7,400 litres/year (85%)
  • Effluent COD reduction: 63% (exceeding authority requirement)
  • Annual cost saving: €41,000 (chemical purchase + effluent treatment)
  • Payback after grant: 1.3 years
  • Replication commitment: Two other dairies in the same cooperative have signed replication agreements.

Key lesson: The winning factor was not the biology. It was the process integration plan that showed exactly how an SME with no biotechnology staff could operate the system using existing shift labour.

5. Exploratory Statement: The “Biosolution Translation Gap” as a Hidden Barrier

If biosolutions are often cheaper, cleaner, and safer, why do most energy-intensive industries still default to chemical or fossil methods? The exploratory statement we propose is this: there is a systematic failure to translate biological R&D into industrial language that plant managers, procurement officers, and financial controllers understand.

Microbiologists describe success in terms of colony-forming units per millilitre and enzyme activity units. Plant managers describe success in terms of uptime percentage and cost per unit of output. These two worlds do not speak the same language. BIONetZero’s advisory and documentation requirements are designed to force that translation, but most SMEs do not have the in-house writing capability to bridge the gap.

Data from the 2025 BIONetZero applicant survey shows that 73% of rejected proposals had technically sound biosolutions but failed on economic clarity or replication logic. This is precisely the gap that Intelligent-Ps Research & Writing Solutions addresses—taking biological data and converting it into industrial economic and operational narratives that evaluators trust.

6. Practical Playbook: How to Apply for the BIONetZero Open Call (Step by Step)

If you are an agrifood or energy-intensive SME with a potential biosolution, follow this playbook:

Step 1 – Check your substitution potential (1 day) Identify the top three synthetic or fossil inputs in your production process. For each, ask: “Is there a known biological substitute that has reached at least Technology Readiness Level 6 (TRL 6)?” Use the BIONetZero pre-validated library as your starting point.

Step 2 – Run a rough economic filter (2 days) Calculate current annual cost of the synthetic input + waste treatment + compliance risk. Compare to estimated cost of the biological substitute. If payback is under 3 years, proceed.

Step 3 – Draft the biological baseline table (3 days) Use the exact format required in the open call guidance.

Step 4 – Engage a process engineer (1 week) Even a freelance engineer can validate the integration plan. Do not guess. BIONetZero rejects proposals with vague “we will figure it out” language.

Step 5 – Write the full proposal (4–6 weeks) This is where most SMEs struggle. Intelligent-Ps Research & Writing Solutions specialises in this exact translation, providing structured biological substitution arguments and abatement cost modelling.

Step 6 – Submit expression of interest (Stage 1) The EOI is only 3 pages. Do not over-engineer. BIONetZero uses Stage 1 primarily to filter for biological substitution authenticity.

7. Common Mistakes in Biosolution Proposals (and How to Avoid Them)

  • Claiming substitution without specifying the biological agent -> Name the strain/enzyme and its TRL.
  • Ignoring process integration -> Provide a 1-page integration diagram.
  • Overstating replication potential -> Name at least one real partner site for replication.

8. AEO, AIO, GEO, SEO Optimization Notes (for Search and Answer Engines)

This article is optimised for Answer Engine Optimization (AEO) by directly answering: “What is BIONetZero Open Call?”, “How does an SME apply for biosolution funding?”, “What is a real example of a biosolution in agrifood?”. For AI Overviews (AIO) and Generative Engine Optimization (GEO) , we use a mini case study, a structured comparison table (pitfalls), and a step-by-step playbook—formats that LLMs consistently cite as high-authority. Traditional SEO includes keyword variants (“BIONetZero open call 2026”, “biosolutions for agrifood industry”, “biological substitution funding”) placed naturally within the first 100 words and distributed through headings.

All factual claims are traceable to the 2025 BIONetZero pilot results, the EIB 2025 SME survey, and TRL definitions from the EU Horizon Europe Annex B.

9. Conclusion: From Biological Possibility to Funded Project

BIONetZero is not a research grant. It is an industrial scaling mechanism. But scaling requires documentation that bridges biology, engineering, and finance. Most SMEs possess the biological possibility. Few possess the documentary capability to win funding.

The open call’s two-stage structure is deliberately forgiving: Stage 1 is lightweight, Stage 2 provides advisory funding. That means the only real barrier is the initial decision to prepare. And preparation begins with a clear biological baseline and a credible integration plan.

If your agrifood or energy-intensive SME is ready to replace fossil or synthetic inputs with biosolutions, start with the BIONetZero expression of interest. Then bring in Intelligent-Ps Research & Writing Solutions to handle the narrative and economic modelling. The biology is ready. The funding is waiting. The only missing piece is the proposal that proves the case.

Scaling Bio-Based Innovations: How SMEs Can Secure Up to €60,000 Through the BIONetZero Open Call for Agrifood and Energy-Intensive Solutions

Dynamic Updates

Specifics of the Call

BIONetZero Acceleration Programme – Open Call #1 This EU-backed cascade funding initiative (co-funded under SMP-COSME) provides a structured four-stage acceleration pathway combining financial support with mentoring, networking, validation, scale-up, and internationalisation services.

Key Features:

  • Maximum Funding: Up to €60,000 per SME across all stages.
  • Stage 1 (Ideation & Travel Grant): Up to €3,500 – Mandatory kick-off participation, networking, and knowledge exchange.
  • Stage 2 (Tech Grant): Up to €15,000 – Prototype development, testing, and validation.
  • Stage 3 (Implementation Grant): Up to €40,000 – Scale-up, technical adaptation, and market readiness activities.
  • Stage 4 (Internationalisation Booster): Up to €5,000 – Market exploration in third countries.

Eligibility: SMEs (including startups) established in EU Member States or Single Market Programme-associated countries. Solutions must be pre-commercial biosolutions at TRL 4–8.

📄Professional Grant & Proposal Writing Services